Clincosm LogoSign in Get a demo

Acute Myeloid Leukemia

Showing 26 - 50 of 1,099
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • TQB2928 Injection + Azacitidine for injection
  • Beijing, Beijing, China
  • +8 more
Aug 22, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • +3 more
  • Universal CD7-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 17, 2023

Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

Recruiting
  • Acute Myeloid Leukemia
  • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
  • Beijing, Beijing, China
  • +2 more
Aug 8, 2023

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

Acute Myeloid Leukemia Trial in Taipei

Enrolling by invitation
  • Acute Myeloid Leukemia
    • Taipei, Taiwan
      National Taiwan University Hospital
    Aug 9, 2023

    Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)

    Recruiting
    • Bortezomib
    • Acute Myeloid Leukemia
    • DAG pre-excitation regimen with Bortezomib
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 31, 2023

    Acute Myeloid Leukemia Trial in Antalya

    Recruiting
    • Acute Myeloid Leukemia
      • Antalya, Turkey
        Antalya Training and Research Hospital
      Jul 29, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +11 more
      • Health Promotion and Education
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 24, 2023

      Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

      Not yet recruiting
      • Graft Vs Host Disease
      • +5 more
      • CliniMACS® device
      • (no location specified)
      Jul 20, 2023

      Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • High-Risk and Very High-Risk Myelodysplastic Syndromes
      • (no location specified)
      Jul 25, 2023

      Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jul 21, 2023

      Acute Myeloid Leukemia Trial in Kunming (Venetoclax in Combination With Azacitidine and HA Regimen)

      Recruiting
      • Acute Myeloid Leukemia
      • Venetoclax in Combination With Azacitidine and HA Regimen
      • Kunming, Yunnan, China
        The Second Affiliated Hospital of Kunming Medical University.
      Jul 10, 2023

      Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • CLL1/+CD33 CAR-T
      • Fuzhou, Fujian, China
        Fujian Provincial Children's Hospital
      Jul 10, 2023

      Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Mitoxantrone hydrochloride liposome injection
      • +3 more
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Jul 1, 2023

      Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)

      Recruiting
      • Acute Myeloid Leukemia
      • Suzhou, Jiangsu, China
      • +1 more
      Jul 3, 2023

      Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

      Recruiting
      • Cancer
      • +4 more
      • INKmune
      • Athens, Attiki, Greece
      • +2 more
      Jul 3, 2023

      Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • Los Angeles, California
      • +9 more
      Jun 27, 2023

      PET Tracer Based FDG Signal for Predicting Prognosis in Acute

      Enrolling by invitation
      • Acute Myeloid Leukemia
      • No intervention
      • Guangzhou, Guangdong, China
        First Affiliated Hospital of Jinan University
      Jun 22, 2023

      Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

      Recruiting
      • Acute Myeloid Leukemia
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 23, 2023

      Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

      Recruiting
      • Acute Myeloid Leukemia
      • Venclexta 100 MG Oral Tablet
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with Nanjing Medical University
      Jun 11, 2023